Search results
A Bird’s Eye View of the Tumor Microenvironment
The Scientist· 4 days agoThe tumor microenvironment is a battleground where infiltrating immune cells either subdue or promote a cancer, all while cancer cells try to dampen the body’s defenses.1,2 Scientists have studied ...
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 2 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
ONESTONE HOLDINGS Achieves Breakthrough in Green Hydrogen Production at Sea With Vertical Wind...
Digital Journal· 4 days ago...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...
CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit...
Benzinga· 7 days agoBragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint ...
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead...
Benzinga· 4 days agoStrasbourg, France, June 3, 2024, 7:30 a.m. CET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the ...
CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on...
Benzinga· 2 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Checkpoint Therapeutics, Inc. CKPT on behalf of long-term stockholders ...